Crimean-congo Hemorrhagic Fever
📧 Sign up to get email alerts when something new happens for Crimean-congo Hemorrhagic Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever [Phase 1]
A Phase 1 study evaluating the safety and immunogenicity of the DNA vaccine N-pVAX1 for Crimean-Congo hemorrhagic fever has completed.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever [Phase 1]
This clinical trial registry entry describes a Phase 1 study evaluating the safety and immunogenicity of a self-amplifying RNA vaccine targe…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing
A research update on developing a rapid diagnostic test for Crimean-Congo hemorrhagic fever, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF [Phase 2]
An update on the adaptive Phase IIb platform trial UMIT-2 evaluating therapeutics for Crimean-Congo Hemorrhagic Fever; the study is not yet …
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF [Phase 1, Phase 2]
Clinical trial update for UMIT-1 evaluating favipiravir and ribavirin in caring for Crimean-Cocol? Crimean-Congo hemorrhagic fever (CCHF) ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans [Phase 1]
Phase I study evaluating basic pharmacodynamic, pharmacological and toxicological effects of a newly developed Crimean-Congo hemorrhagic fev…